​

Funding Round

Seed Round - ReviR Therapeutics

Seed Round - ReviR Therapeutics

Investment Firm

Overview

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Announced Date

Jan 17, 2022

Funding Type

Seed

Highlights

Location

United States, North America

Social

Investor Lead

CDH Investments

CDH Investments

CDH Investments is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

5Y Capital

5Y Capital

5Y Capital is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorShunwei Capital
Participant Investor5Y Capital
Participant InvestorCDH Investments
Participant InvestorTiantu Capital
Participant InvestorSky9 Capital

Round Details and Background

ReviR Therapeutics raised $20000000 on 2022-01-17 in Seed Round

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 17, 2022
Seed Round - ReviR Therapeutics
5-20.0M
Jun 19, 2024
Grant - ReviR Therapeutics
1-undefined
Jul 26, 2024
Series A - ReviR Therapeutics
6-30.0M

Recent Activity

There is no recent news or activity for this profile.